Pharma companies’ local sales increased 30% y-o-y in 1Q2017 to reach EGP 11.5 bn, Al Borsa reports, citing a report from American healthcare information company IMS Health. According to the report, Novartis’ achieved the highest sales of the quarter at EGP 980 mn, marking a 32% y-o-y increase.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
EGX30 gained 2.79% in 3Q, but September gave back most of its July-August run, with mid-caps falling the hardest
Small- and mid-cap indices widened their lead over the benchmark…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…